Original Article

Subject Category: Wound Healing

Journal of Investigative Dermatology (2009) 129, 752–764; doi:10.1038/jid.2008.230; published online 31 July 2008

Akt1 Controls Insulin-Driven VEGF Biosynthesis from Keratinocytes: Implications for Normal and Diabetes-Impaired Skin Repair in Mice

Itamar Goren1,3, Elke Müller1,3, Dana Schiefelbein1, Paul Gutwein1, Oliver Seitz2, Josef Pfeilschifter1 and Stefan Frank1

  1. 1Pharmazentrum Frankfurt/ZAFES, Frankfurt am Main, Germany
  2. 2Klinik für Mund-, Kiefer und Plastische Gesichtschirurgie, Klinikum der Johann Wolfgang Goethe-Universität, Frankfurt am Main, Germany

Correspondence: Dr Stefan Frank, Pharmazentrum Frankfurt, Institut für Allgemeine Pharmakologie und Toxikologie, Klinikum der JW Goethe-Universität Frankfurt/M., Theodor-Stern-Kai 7, D-60590 Frankfurt/M., Germany. E-mail: s.frank@em.uni-frankfurt.de

3These authors contributed equally to this study

Received 14 December 2007; Revised 24 April 2008; Accepted 5 May 2008; Published online 31 July 2008.

Top

Abstract

Here we investigated the potential role of protein kinase B (Akt) in normal or diabetes-impaired wound healing in mice. Interestingly, Akt1 was predominant in skin, wound tissue, and human keratinocytes cell line. Acute skin repair was characterized by an increase of Akt1 phosphorylation in wound margin keratinocytes. By contrast, phosphorylated Akt1 was nearly completely absent and paralleled by a poor phosphorylation of the eucaryotic initiation factor 4E-binding protein 1 (4E-BP1) and reduced levels of vascular endothelial growth factor (VEGF) protein in chronic wounds of diabetic ob/ob mice. Inhibition of the phosphatidyl-inositol-3 kinase/Akt pathway by wortmannin and specific abrogation of Akt1 protein using small-interfering RNA revealed a regulatory function of Akt1 in insulin-mediated VEGF biosynthesis in keratinocytes. Insulin-induced VEGF protein biosynthesis in keratinocytes was mediated by Akt1 from a constitutive VEGF-encoding mRNA pool at the posttranscriptional level through a downstream phosphorylation 4E-BP1. Moreover, transfection experiments introducing a constitutively active mutant of Akt1 into keratinocytes revealed the mammalian target of rapamycin kinase as a downstream mediator of Akt1-linked 4E-BP1 phosphorylation and translational control. Our data suggest that the endocrine hormone insulin contributes to VEGF release in skin wounds through an Akt1-mediated posttranscriptional mechanism in keratinocytes.

Abbreviations:

Akt, protein kinase B; 4E-BP1, eucaryotic initiation factor 4E-binding protein; EGF, epidermal growth factor; GSK, glycogen synthase kinase; HaCaT, human keratinocyte cell line; mTOR, mammalian target of rapamycin; PI3K, phosphatidyl-inositol-3 kinase; siRNA, small-interfering RNA; VEGF, vascular endothelial growth factor

Extra navigation

.
ADVERTISEMENT